PSI Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
AIM
ACG
NAMA
GA
PSI Advisors's DNA Position: Q2 2023 in Review
PSI Advisors sold out of Ginkgo Bioworks (DNA) in Q2 2023, closing a stake of 13 shares — an estimated $665 sold.
PSI Advisors first reported a position in DNA in Q2 2022 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.
- PSI Advisors reported no remaining Ginkgo Bioworks position as of Q2 2023 after selling out during the quarter.
- PSI Advisors sold 13 Ginkgo Bioworks shares in Q2 2023, an estimated $665.
- PSI Advisors first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 4 quarters.
- PSI Advisors's Ginkgo Bioworks position peaked at $2K in Q3 2022.
- 315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.
Based on PSI Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.